NCT04915755
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04915755
Title Efficacy and Safety Comparison of Niraparib to Placebo in Participants With Human Epidermal Growth Factor 2 Negative (HER2-) Breast Cancer Susceptibility Gene Mutation (BRCAmut) or Triple-Negative Breast Cancer (TNBC) With Molecular Disease (ZEST)
Acronym ZEST
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors GlaxoSmithKline
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ROU | POL | NOR | NLD | ITA | ISR | IRL | HUN | GBR | FRA | FIN | ESP | DEU | CHE | CAN | BRA | BEL | AUT | AUS | ARG

Facility Status City State Zip Country Details
GSK Investigational Site Burbank California 91505 United States Details
GSK Investigational Site Duarte California 91010 United States Details
GSK Investigational Site Palo Alto California 94304 United States Details
GSK Investigational Site San Francisco California 94158 United States Details
GSK Investigational Site Aurora Colorado 80045 United States Details
GSK Investigational Site Highlands Ranch Colorado 80045 United States Details
GSK Investigational Site Chicago Illinois 60612 United States Details
GSK Investigational Site Skokie Illinois 60076 United States Details
GSK Investigational Site Ann Arbor Michigan 48109 United States Details
GSK Investigational Site Albuquerque New Mexico 87106 United States Details
GSK Investigational Site New York New York 10032 United States Details
GSK Investigational Site Fargo North Dakota 58122 United States Details
GSK Investigational Site Philadelphia Pennsylvania 19111 United States Details
GSK Investigational Site Pittsburgh Pennsylvania 15213 United States Details
GSK Investigational Site Sioux Falls South Dakota 57104 United States Details
GSK Investigational Site Austin Texas 78731 United States Details
GSK Investigational Site Dallas Texas 75231 United States Details
GSK Investigational Site Dallas Texas 75246 United States Details
GSK Investigational Site Fort Worth Texas 76104 United States Details
GSK Investigational Site Houston Texas 77024 United States Details
GSK Investigational Site San Antonio Texas 78240 United States Details
GSK Investigational Site Tyler Texas 75702 United States Details
GSK Investigational Site Norfolk Virginia 23502 United States Details
GSK Investigational Site Everett Washington 98201 United States Details
GSK Investigational Site Buenos Aires C1017 AAS Argentina Details
GSK Investigational Site Buenos Aires C1125ABD Argentina Details
GSK Investigational Site Buenos Aires C1426ABP Argentina Details
GSK Investigational Site Capital Federal C1426ANZ Argentina Details
GSK Investigational Site Cipoletti Rio Negro R8324CVE Argentina Details
GSK Investigational Site Ciudad Autonoma Buenos Aires C1430EGF Argentina Details
GSK Investigational Site Ciudad AutOnoma de Buenos Aire C1015ABO Argentina Details
GSK Investigational Site Ciudad Autonoma de Buenos Aire C1426AGE Argentina Details
GSK Investigational Site Ciudad de Buenos Aires C1118AAT Argentina Details
GSK Investigational Site Entre Ríos 2822 Argentina Details
GSK Investigational Site Camperdown New South Wales 2050 Australia Details
GSK Investigational Site Macquarie Park New South Wales 2109 Australia Details
GSK Investigational Site North Sydney New South Wales 2060 Australia Details
GSK Investigational Site Feldkirch A-6830 Austria Details
GSK Investigational Site Innsbruck 6020 Austria Details
GSK Investigational Site Steyr 4400 Austria Details
GSK Investigational Site Vienna A-1090 Austria Details
GSK Investigational Site Brussels 1070 Belgium Details
GSK Investigational Site Brussels 1200 Belgium Details
GSK Investigational Site Charleroi 6000 Belgium Details
GSK Investigational Site Ghent 9000 Belgium Details
GSK Investigational Site Leuven 3000 Belgium Details
GSK Investigational Site Belo Horizonte 30130-100 Brazil Details
GSK Investigational Site Florianópolis 88034-000 Brazil Details
GSK Investigational Site Porto Alegre 90020-090 Brazil Details
GSK Investigational Site Porto Alegre 90610000 Brazil Details
GSK Investigational Site Rio de Janeiro 20560-120 Brazil Details
GSK Investigational Site Rio Grande 95070-560 Brazil Details
GSK Investigational Site Salvador 40170-110 Brazil Details
GSK Investigational Site São Paulo 01317000 Brazil Details
GSK Investigational Site São Paulo 04312903 Brazil Details
GSK Investigational Site Vitória 29043-260 Brazil Details
GSK Investigational Site Calgary Alberta T2N 4N2 Canada Details
GSK Investigational Site Toronto Ontario M4N 3M5 Canada Details
GSK Investigational Site Toronto Ontario M5G 2M9 Canada Details
GSK Investigational Site Montreal Quebec H3T 1E2 Canada Details
GSK Investigational Site Québec Quebec G1S 4L8 Canada Details
GSK Investigational Site Santiago 7500653 Chile Details
GSK Investigational Site Santiago 7500836 Chile Details
GSK Investigational Site Temuco 5360000 Chile Details
GSK Investigational Site Helsinki 00180 Finland Details
GSK Investigational Site Helsinki HUS 00029 Finland Details
GSK Investigational Site Turku 20520 Finland Details
GSK Investigational Site Avignon 84918 France Details
GSK Investigational Site Bordeaux 33076 France Details
GSK Investigational Site Caen 14000 France Details
GSK Investigational Site Dijon 21000 France Details
GSK Investigational Site Marseille 13915 France Details
GSK Investigational Site Montpellier 34070 France Details
GSK Investigational Site Pierre-Bénite 69495 France Details
GSK Investigational Site Rouen 76000 France Details
GSK Investigational Site Saint-Cloud 92210 France Details
GSK Investigational Site Berlin 13125 Germany Details
GSK Investigational Site Cologne 50935 Germany Details
GSK Investigational Site Erlangen 91054 Germany Details
GSK Investigational Site Essen 45136 Germany Details
GSK Investigational Site Mannheim 68167 Germany Details
GSK Investigational Site München 81377 Germany Details
GSK Investigational Site Ulm 89075 Germany Details
GSK Investigational Site Debrecen 4032 Hungary Details
GSK Investigational Site Dublin 8 Ireland Details
GSK Investigational Site Dublin 9 Ireland Details
GSK Investigational Site Beersheba 84101 Israel Details
GSK Investigational Site Haifa 31096 Israel Details
GSK Investigational Site Jerusalem 91031 Israel Details
GSK Investigational Site Jerusalem 91120 Israel Details
GSK Investigational Site Petah Tikva 49100 Israel Details
GSK Investigational Site Rehovot 76100 Israel Details
GSK Investigational Site Tel Aviv 64239 Israel Details
GSK Investigational Site Ancona 60126 Italy Details
GSK Investigational Site Ancona 62100 Italy Details
GSK Investigational Site Bologna 40138 Italy Details
GSK Investigational Site Brindisi 72100 Italy Details
GSK Investigational Site Candiolo to 10060 Italy Details
GSK Investigational Site Catania 95122 Italy Details
GSK Investigational Site Genova 16132 Italy Details
GSK Investigational Site Meldola FC 47014 Italy Details
GSK Investigational Site Milan 20141 Italy Details
GSK Investigational Site Milan 20157 Italy Details
GSK Investigational Site Monza 20900 Italy Details
GSK Investigational Site Napoli 80131 Italy Details
GSK Investigational Site Negrar Verona 37024 Italy Details
GSK Investigational Site Padua 35128 Italy Details
GSK Investigational Site Aichi 464-8681 Japan Details
GSK Investigational Site Chiba 277-8577 Japan Details
GSK Investigational Site Ehime 791-0280 Japan Details
GSK Investigational Site Fukuoka 811-1395 Japan Details
GSK Investigational Site Hiroshima 730-8518 Japan Details
GSK Investigational Site Hokkaido 003-0804 Japan Details
GSK Investigational Site Kagoshima 892-0833 Japan Details
GSK Investigational Site Kanagawa 216-8511 Japan Details
GSK Investigational Site Kanagawa 241-8515 Japan Details
GSK Investigational Site Kanagawa 259-1143 Japan Details
GSK Investigational Site Okayama 700-8558 Japan Details
GSK Investigational Site Osaka 541-8567 Japan Details
GSK Investigational Site Osaka 589-8511 Japan Details
GSK Investigational Site Saitama 350-1298 Japan Details
GSK Investigational Site Saitama 350-8550 Japan Details
GSK Investigational Site Saitama 362-0806 Japan Details
GSK Investigational Site Tokyo 104-0045 Japan Details
GSK Investigational Site Tokyo 113-8431 Japan Details
GSK Investigational Site Tokyo 135-8550 Japan Details
GSK Investigational Site Tokyo 142-8666 Japan Details
GSK Investigational Site León 37178 Mexico Details
GSK Investigational Site Mexico City 04980 Mexico Details
GSK Investigational Site Monterrey 64460 Mexico Details
GSK Investigational Site Monterrey 66278 Mexico Details
GSK Investigational Site Alkmaar 1815 JD Netherlands Details
GSK Investigational Site Leeuwarden 8934 AD Netherlands Details
GSK Investigational Site Maastricht 6229 HX Netherlands Details
GSK Investigational Site Rotterdam 3083 AN Netherlands Details
GSK Investigational Site The Hague 2545 AA Netherlands Details
GSK Investigational Site Zwolle 8025 AB Netherlands Details
GSK Investigational Site Drammen N-3004 Norway Details
GSK Investigational Site Stavanger 4011 Norway Details
GSK Investigational Site Katowice 40-514 Poland Details
GSK Investigational Site Krakow 31-115 Poland Details
GSK Investigational Site Krakow 31-501 Poland Details
GSK Investigational Site Olsztyn 10-228 Poland Details
GSK Investigational Site Poznan 61-866 Poland Details
GSK Investigational Site Rzeszów 35-021 Poland Details
GSK Investigational Site Siedlce 08-110 Poland Details
GSK Investigational Site Szczecin 70-707 Poland Details
GSK Investigational Site Warsaw 02-781 Poland Details
GSK Investigational Site Wroclaw 53-413 Poland Details
GSK Investigational Site Lisbon 1649-035 Portugal Details
GSK Investigational Site Loures 2674-514 Portugal Details
GSK Investigational Site Bucharest 011171 Romania Details
GSK Investigational Site Bucharest 020142 Romania Details
GSK Investigational Site Bucharest 021389 Romania Details
GSK Investigational Site Bucharest 022343 Romania Details
GSK Investigational Site Cluj-Napoca 400015 Romania Details
GSK Investigational Site Craiova 200347 Romania Details
GSK Investigational Site Otopeni 075100 Romania Details
GSK Investigational Site Timișoara 300239 Romania Details
GSK Investigational Site Chelyabinsk 454048 Russia Details
GSK Investigational Site Moscow 111123 Russia Details
GSK Investigational Site Moscow 121309 Russia Details
GSK Investigational Site Moscow 143422 Russia Details
GSK Investigational Site Omsk 644013 Russia Details
GSK Investigational Site Pushkin 196603 Russia Details
GSK Investigational Site Saint Petersburg 197110 Russia Details
GSK Investigational Site Saint Petersburg 197758 Russia Details
GSK Investigational Site StPetersburg 197022 Russia Details
GSK Investigational Site Cape Town 7700 South Africa Details
GSK Investigational Site Port Elizabeth 6045 South Africa Details
GSK Investigational Site Pretoria 0041 South Africa Details
GSK Investigational Site Barcelona 08003 Spain Details
GSK Investigational Site Barcelona 08028 Spain Details
GSK Investigational Site Barcelona 08035 Spain Details
GSK Investigational Site Cáceres 10003 Spain Details
GSK Investigational Site Córdoba 14004 Spain Details
GSK Investigational Site Granada 18016 Spain Details
GSK Investigational Site Madrid 28034 Spain Details
GSK Investigational Site Madrid 28041 Spain Details
GSK Investigational Site Madrid 28046 Spain Details
GSK Investigational Site Madrid 28050 Spain Details
GSK Investigational Site Málaga 29010 Spain Details
GSK Investigational Site Santiago de Compostela 15706 Spain Details
GSK Investigational Site Valencia 46010 Spain Details
GSK Investigational Site Zaragoza 50009 Spain Details
GSK Investigational Site Basel 4031 Switzerland Details
GSK Investigational Site Bath BA1 3NG United Kingdom Details
GSK Investigational Site Brighton BN2 5BE United Kingdom Details
GSK Investigational Site Cardiff CF14 2TL United Kingdom Details
GSK Investigational Site Coventry CV2 2DX United Kingdom Details
GSK Investigational Site Edinburgh EH4 2XU United Kingdom Details
GSK Investigational Site Leeds LS9 7TF United Kingdom Details
GSK Investigational Site London SE1 9RT United Kingdom Details
GSK Investigational Site London SW3 6JJ United Kingdom Details
GSK Investigational Site Maidstone ME16 9QQ United Kingdom Details
GSK Investigational Site Manchester M20 4BX United Kingdom Details
GSK Investigational Site Sutton SM2 5PT United Kingdom Details
GSK Investigational Site Wigan WN1 2NN United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field